Properties of calprotectin

Andersson KB, Sletten K, Berntzen HB, Dale I, Brandtzaeg P, Jellum E, Fagerhol MK. The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28(2): 241-5.

PMID#: 3413449


Berntzen HB, Fagerhol MK. L1, a major granulocyte protein: antigenic properties of its subunits. Scand J Clin Lab Invest 1988; 48(7): 647-52.

PMID#: 3144035


Berntzen HB, Fagerhol MK. L1, a major granulocyte protein; isolation of high quantities of its subunits. Scand J Clin Lab Invest 1990; 50(7):769-74.

PMID#: 2293338


Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor in epithelial surfaces. Adv Exp Med Biol 1995; 371A: 201-6.

PMID#: 8525906


Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21(4): 733-8.

PMID#: 8035402


Brun JG, Ulvestad E, Fagerhol MK, Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 1994; 40(6): 675-80.

PMID#: 7997858


Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 1995; 42(5):551-6.

PMID#: 7481561


Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Europ J Biochem 1983; 134(1): 1-6.

PMID#: 6861753


Fagerhol MK, Dale I, Andersson T. Release and quantitation of a leukocyte derived protein (L1). Scand J Haematol 1980; 24: 393-8.


Fagerhol MK. Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein ? J Clin Pathol 1996; 49: 74-79


Mambula SS, Simons ER, Hastey R, Selsted ME, Levitz SM. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infection & Immunity 2000; 68(11): 6257-64.

PMID#: 11035733


Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun 2001; 69(6): 3692-96.

PMID#: 11349032


Okutomi T, Tanaka T, Yui S, Mikami M, Yamazaki M, Abe S, Yamaguchi H. Anti-Candida activity of calprotectin in combination with neutrophils or lectoferrin. Microbiol Immunol 1998; 42(11): 789-93.

PMID#: 9886152


Pechkovsky DV, Zalutskaya OM, Ivanov GI, Misuno NI. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol 2000; 29(1): 27-33.

PMID#: 10967257


Sohnle PG, Hahn BL. Effect of zinc-reversible growth-inhibitory activity in human empyema fluid on antibiotic microbicidal activity. Antimicrob Agents Chemother 2000; 44(1):139-42.

PMID#: 10602735


Sohnle PG, Hunter MJ, Hahn B, Chazin WJ. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis 2000; 182(4):1272-5.

PMID#: 10979933


  • Anne Thjømøe

    Executive Chairman 


    Direct line: +47 97 73 37 51

  • Anne Hancke Framstad

    Laboratory Quality Specialist


    Direct line: +47 92 01 14 91

  • Einar Mørk

    Dir. Operations


    Direct line: +47 47 28 55 61

  • Mona Schartum

    Production Manager


    Direct line: +47 93 22 73 63

  • Ingvild haukø bilde

    Ingvild Haukø

    Sales- and Marketing Manager


    Direct line: +47 92 01 52 18

  • Ali Qamar

    Product Manager


    Direct line: +47 41 17 81 19

General Information

Fecal calprotectin in differential diagnosis of irritable bowel syndrome

Li XG, Lv YM, Gu F, Yang XL., Department of Gastroenterology, Peking University Third May 9, 2015

Latest News

Calpro press release regarding MSD agreement

Please see the Calpro press release regarding MDS agreement for delivery of e-health technology CalproSmart:

Norsk | English October 13, 2016

View all latest

Share This